{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:32:43Z","timestamp":1793572363331,"version":"4.5.0"},"reference-count":31,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Antigenic divergence has been found between\n            <jats:italic>Bordetella pertussis<\/jats:italic>\n            vaccine strains and circulating strains in several countries. In the present study, we analyzed\n            <jats:italic>B. pertussis<\/jats:italic>\n            isolates collected in Japan from 1988 to 2001 using pulsed-field gel electrophoresis (PFGE) and sequencing of two virulence-associated proteins. The 107 isolates were classified into three major groups by PFGE analysis; 87 (81%) were type A, 19 (18%) were type B, and 1 (1%) was type C. Sequence analysis of the S1 subunit of pertussis toxin (\n            <jats:italic>ptxS1<\/jats:italic>\n            ) and adhesion pertactin (\n            <jats:italic>prn<\/jats:italic>\n            ) genes revealed the presence of two (\n            <jats:italic>ptxS1A<\/jats:italic>\n            and\n            <jats:italic>ptxS1B<\/jats:italic>\n            ) and three (\n            <jats:italic>prn1<\/jats:italic>\n            ,\n            <jats:italic>prn2<\/jats:italic>\n            , and\n            <jats:italic>prn3<\/jats:italic>\n            ) variants, respectively, in the isolates. Among those isolates, 82 (95%) of the 87 type A strains and the type C strain had the same combination of\n            <jats:italic>ptxS1B<\/jats:italic>\n            and\n            <jats:italic>prn1<\/jats:italic>\n            alleles (\n            <jats:italic>ptxS1B\/prn1<\/jats:italic>\n            ) as the Japanese vaccine strain. On the other hand, 17 (90%) of 19 type B strains had an allele (\n            <jats:italic>ptxS1A\/prn2<\/jats:italic>\n            ) distinct from that of the vaccine strain. A correlation was found between the antigenic variation and the PFGE profile in the isolates. In addition, the frequency of the type B strain was 0, 27, 0, 42, and 37% of the isolates in the periods 1988 to 1993, 1994 to 1995, 1996 to 1997, 1998 to 1999, and 2000 to 2001, respectively. In contrast, the number of reported pertussis-like and pertussis cases decreased gradually from 1991 on, suggesting that the antigenic divergence did not affect the efficacy of pertussis vaccination in Japan.\n          <\/jats:p>","DOI":"10.1128\/jcm.42.12.5453-5457.2004","type":"journal-article","created":{"date-parts":[[2004,12,6]],"date-time":"2004-12-06T23:38:07Z","timestamp":1102376287000},"page":"5453-5457","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":30,"title":["Antigenic Divergence Suggested by Correlation between Antigenic Variation and Pulsed-Field Gel Electrophoresis Profiles of\n            <i>Bordetella pertussis<\/i>\n            Isolates in Japan"],"prefix":"10.1128","volume":"42","author":[{"given":"Atsuko","family":"Kodama","sequence":"first","affiliation":[{"name":"Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases"},{"name":"Department of Biological Science, Graduate School of Science, Tokyo Metropolitan University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Kamachi","sequence":"additional","affiliation":[{"name":"Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Horiuchi","sequence":"additional","affiliation":[{"name":"Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Konda","sequence":"additional","affiliation":[{"name":"Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshichika","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"145","volume":"21","year":"1997","unstructured":"Andrews, R., A. Herceg, and C. Roberts. 1997. Pertussis notifications in Australia, 1991 to 1997. Commun. Dis. Intell.21:145-148.","journal-title":"Commun. Dis. Intell."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00038-9"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/315881"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-148-9-2765"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0604.000404"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.9.5520-5528.2001"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00013-5"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/514776"},{"key":"e_1_3_2_10_2","first-page":"299","volume":"20","year":"2002","unstructured":"Gzyl, A., E. Augustynowicz, I. van Loo, and J. Slusarczyk. 2002. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine20:299-303.","journal-title":"Vaccine"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0801.010021"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.6.3763-3767.2000"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/368412"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.40.3.1198-1203.1983"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-2508(89)90069-7"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-147-11-2885"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.8.3706-3711.2003"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.8.3465-3468.1997"},{"key":"e_1_3_2_19_2","first-page":"174","volume":"13","year":"2000","unstructured":"Mooi, F. R., H. Hallander, C. H. Wirsing von K\u00f6nig, B. Hoet, and N. Guiso. 2000. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. Clin. Infect. Dis. J.13:174-181.","journal-title":"Eur. Clin. Infect. Dis. J."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.6.3133-3134.1999"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.2.670-675.1998"},{"key":"e_1_3_2_22_2","first-page":"101","volume":"18","year":"1997","unstructured":"National Institute of Infectious Diseases. 1997. Pertussis, Japan, 1982-1996. Infect. Agents Surveill. Rep.18:101-102.","journal-title":"Infect. Agents Surveill. Rep."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.7.3344-3347.2003"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(85)90004-0"},{"key":"e_1_3_2_25_2","first-page":"122","year":"1984","unstructured":"Sato, Y., M. Kimura, and H. Fukumi. 1984. Development of a pertussis component vaccine in Japan. Lanceti:122-126.","journal-title":"Lancet"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)43911-1"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.11.6475-6480.2002"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268899003052"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.6.1994-2001.2002"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-148-7-2011"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1086\/314690"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.12.4396-4403.2001"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.42.12.5453-5457.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.42.12.5453-5457.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T02:50:46Z","timestamp":1646448646000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.42.12.5453-5457.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1128\/JCM.42.12.5453-5457.2004"],"URL":"https:\/\/doi.org\/10.1128\/jcm.42.12.5453-5457.2004","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"2004-04-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-08-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}